JONATHAN TOBIN is listed as a director on 2 SEC Form D filings by 1 issuer between Mar 2018 and Apr 2019: Atox Bio Inc. (Ness Ziona, Israel (as filed: L3) — biotechnology — 2018–2019; $33M reported sold to 15 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside ANAT SHIRVAN (2 shared filings), CASPER BREUM (2 shared filings), DANE ROSS (2 shared filings), Dan Teleman (2 shared filings), Daniel D Burgess (2 shared filings) and 7 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around JONATHAN. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 2 bankruptcy cases matching the name listed in Key records below.
What this means 2 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 2 public filings for JONATHAN TOBIN and found 4 differences, 1 worth asking the sponsor about: Form D filed 101 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.